A phase II, open-label, randomized, multicenter trial of encorafenib + binimetinib evaluating a standard-dose and a high-dose regimen in patients with BRAFV600-mutant melanoma brain metastasis (MBM) (POLARIS)
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s | |
| Publication date | October 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://linkinghub.elsevier.com/retrieve/pii/S0923753419595886 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |